US Bancorp DE Lowers Stake in Amdocs Limited (NASDAQ:DOX)

US Bancorp DE lessened its position in shares of Amdocs Limited (NASDAQ:DOX) by 6.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 14,889 shares of the technology company’s stock after selling 1,061 shares during the period. US Bancorp DE’s holdings in Amdocs were worth $1,268,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in DOX. Pzena Investment Management LLC grew its position in Amdocs by 12.3% during the third quarter. Pzena Investment Management LLC now owns 6,363,739 shares of the technology company’s stock valued at $556,700,000 after acquiring an additional 696,136 shares during the period. Hotchkis & Wiley Capital Management LLC grew its position in Amdocs by 123.2% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 759,136 shares of the technology company’s stock valued at $66,409,000 after acquiring an additional 419,045 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Amdocs by 1,207.3% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 271,701 shares of the technology company’s stock valued at $23,768,000 after acquiring an additional 250,918 shares during the period. Geode Capital Management LLC grew its position in Amdocs by 10.8% during the third quarter. Geode Capital Management LLC now owns 1,633,733 shares of the technology company’s stock valued at $143,498,000 after acquiring an additional 158,843 shares during the period. Finally, Nordea Investment Management AB grew its position in Amdocs by 8.3% during the fourth quarter. Nordea Investment Management AB now owns 1,656,055 shares of the technology company’s stock valued at $141,112,000 after acquiring an additional 127,426 shares during the period. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Price Performance

Shares of NASDAQ DOX opened at $90.46 on Friday. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20. Amdocs Limited has a 1-year low of $74.41 and a 1-year high of $94.04. The business has a 50-day moving average of $86.36 and a 200-day moving average of $86.96. The company has a market capitalization of $10.21 billion, a price-to-earnings ratio of 20.99, a PEG ratio of 1.47 and a beta of 0.68.

Amdocs (NASDAQ:DOX) last released its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. On average, equities analysts anticipate that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Monday, March 31st will be paid a $0.527 dividend. This is a boost from Amdocs’s previous quarterly dividend of $0.48. The ex-dividend date is Monday, March 31st. This represents a $2.11 annualized dividend and a dividend yield of 2.33%. Amdocs’s payout ratio is 48.72%.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Oppenheimer upped their target price on Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. Barclays decreased their target price on Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a research report on Thursday, November 14th. Finally, StockNews.com downgraded Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $101.20.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.